• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)与营养]

[Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition].

作者信息

Ishii Kiyo-aki, Takamura Toshinari

机构信息

Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Japan.

Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences, Japan.

出版信息

Clin Calcium. 2016 Mar;26(3):363-7.

PMID:26923972
Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive fat accumulation in the form of triglycerides in the hepatocytes. A more severe form of NAFLD with necrosis, inflammation, and fibrosis is called non-alcoholic steatohepatitis (NASH). The liver is located in the center of the body's organ network and acts as a coordinator of glucose and lipid metabolism. Therefore, it is important to perform nutritional therapy of patients with NAFLD/NASH while maintaining the energy balance in the entire body.

摘要

非酒精性脂肪性肝病(NAFLD)的特征是肝细胞内以甘油三酯形式存在的脂肪过度蓄积。NAFLD更严重的形式伴有坏死、炎症和纤维化,称为非酒精性脂肪性肝炎(NASH)。肝脏位于身体器官网络的中心,起着协调葡萄糖和脂质代谢的作用。因此,在维持全身能量平衡的同时,对NAFLD/NASH患者进行营养治疗非常重要。

相似文献

1
[Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition].[非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)与营养]
Clin Calcium. 2016 Mar;26(3):363-7.
2
Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.蛋白激酶STK25调节肝脏脂质分配以及肝脂肪变性和非酒精性脂肪性肝炎的进展。
FASEB J. 2015 Apr;29(4):1564-76. doi: 10.1096/fj.14-264937. Epub 2015 Jan 21.
3
Effect of resveratrol on experimental non-alcoholic steatohepatitis.白藜芦醇对实验性非酒精性脂肪性肝炎的影响。
Pharmacol Res. 2015 May-Jun;95-96:34-41. doi: 10.1016/j.phrs.2015.03.005. Epub 2015 Mar 23.
4
Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology.大鼠酒精性与非酒精性脂肪肝:尽管病理相似,但内吞作用和囊泡运输存在明显差异。
BMC Gastroenterol. 2016 Feb 29;16:27. doi: 10.1186/s12876-016-0433-4.
5
Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.高脂高胆固醇饮食诱导的实验性非酒精性脂肪性肝炎模型SHRSP5/Dmcr中肝脏病变的病理特征及形态计量分析
Int J Exp Pathol. 2016 Feb;97(1):75-85. doi: 10.1111/iep.12169. Epub 2016 Mar 31.
6
Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease.与非酒精性脂肪性肝病进展相关的脂质种类鉴定
Curr Drug Targets. 2015;16(12):1293-300. doi: 10.2174/1389450116666150408103318.
7
The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).肿瘤抑制因子 RASSF1A、RUNX3 和 GSTP1 在酒精性脂肪性肝炎(ASH)与非酒精性脂肪性肝炎(NASH)患者中的不同表达。
Exp Mol Pathol. 2019 Jun;108:156-163. doi: 10.1016/j.yexmp.2019.04.002. Epub 2019 Apr 3.
8
Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).用于诊断非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的单一非侵入性模型。
J Gastroenterol Hepatol. 2014 Dec;29(12):2006-13. doi: 10.1111/jgh.12665.
9
Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis.非酒精性脂肪性肝病是一种内源性酒精性脂肪性肝病吗?——一种机制假说。
Med Hypotheses. 2015 Aug;85(2):148-52. doi: 10.1016/j.mehy.2015.04.021. Epub 2015 Apr 29.
10
Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition.非酒精性脂肪性肝病与营养之间联系的表观遗传机制
Nutrients. 2014 Aug 21;6(8):3303-25. doi: 10.3390/nu6083303.

引用本文的文献

1
Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.基于串联质量标签标记与标记结合液相色谱-串联质谱的定量蛋白质组学分析发现水飞蓟宾对小鼠非酒精性脂肪肝的作用。
Bioengineered. 2022 Mar;13(3):6750-6766. doi: 10.1080/21655979.2022.2045837.
2
2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside attenuates methionine and choline-deficient diet-induced non-alcoholic fatty liver disease.2,3,5,4'-四羟基二苯乙烯-2-O-β-D-葡萄糖苷减轻蛋氨酸和胆碱缺乏饮食诱导的非酒精性脂肪性肝病。
Exp Ther Med. 2018 Aug;16(2):1087-1094. doi: 10.3892/etm.2018.6300. Epub 2018 Jun 13.